Abstract
Background: Cancer cells are more susceptible than normal cells to the effect of chemotherapeutic agents and most of the anticancer drugs can cause harm to the normal cells. Optimum dose and frequency are both important factors in the persistence of cancer cells during cancer chemotherapy. Now attempts have been focusing on efforts to kill cancer cells by more specific targeting while sparing the normal cells by drug loaded nanocarriers.
Methods: We review technical papers and other articles related to nanoparticles, which have been developed as effective target specific strategies for cancer treatment, acting as nanocarriers and also as active agents.
Results: This review will allow to gain a more general view of the various drug loaded nanocarriers which offers a predominantly unique set of chemical, physical and photonic properties for better drug delivery to the tumor tissues based on morphological and functional differences between normal and tumor tissues.
Conclusion: Nanoparticulate delivery systems in cancer therapies provide better penetration of therapeutic and diagnostic substances with the cancerous tissue in comparison to conventional cancer therapies. Thus nanocarriers can be used for strategic development of novel drug delivery systems and reformulating existing drugs to enhance effectiveness.
Keywords: Active targeting, antibody based therapy, passive targeting, receptor, targeting tumors, tumor site.
Current Biotechnology
Title:Drug-Loaded Nanocarriers in Tumor Targeted Drug Delivery
Volume: 4 Issue: 3
Author(s): Meerza Abdul Razak, Shankarappa Devi Prasad Boggupalli and Buddolla Viswanath
Affiliation:
Keywords: Active targeting, antibody based therapy, passive targeting, receptor, targeting tumors, tumor site.
Abstract: Background: Cancer cells are more susceptible than normal cells to the effect of chemotherapeutic agents and most of the anticancer drugs can cause harm to the normal cells. Optimum dose and frequency are both important factors in the persistence of cancer cells during cancer chemotherapy. Now attempts have been focusing on efforts to kill cancer cells by more specific targeting while sparing the normal cells by drug loaded nanocarriers.
Methods: We review technical papers and other articles related to nanoparticles, which have been developed as effective target specific strategies for cancer treatment, acting as nanocarriers and also as active agents.
Results: This review will allow to gain a more general view of the various drug loaded nanocarriers which offers a predominantly unique set of chemical, physical and photonic properties for better drug delivery to the tumor tissues based on morphological and functional differences between normal and tumor tissues.
Conclusion: Nanoparticulate delivery systems in cancer therapies provide better penetration of therapeutic and diagnostic substances with the cancerous tissue in comparison to conventional cancer therapies. Thus nanocarriers can be used for strategic development of novel drug delivery systems and reformulating existing drugs to enhance effectiveness.
Export Options
About this article
Cite this article as:
Razak Abdul Meerza, Prasad Boggupalli Devi Shankarappa and Viswanath Buddolla, Drug-Loaded Nanocarriers in Tumor Targeted Drug Delivery, Current Biotechnology 2015; 4 (3) . https://dx.doi.org/10.2174/2211550104666150525221950
DOI https://dx.doi.org/10.2174/2211550104666150525221950 |
Print ISSN 2211-5501 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-551X |
Call for Papers in Thematic Issues
Age Reversal using transient epigenetc reprogramming with the OSK Yamanaka Factors
Aging is a complex biological process characterized by a gradual deterioration of physiological functions and an increased vulnerability to disease. Recent advancements in the field of regenerative medicine have shown promising avenues for combating aging. Among these, partial epigenetic reprogramming, specifically utilizing the Yamanaka factors, has been shown to reverse ...read more
Bioinformatic Analysis of Regulated Cell Death in Chronic and Acute Inflammatory Diseases
In the intricate realm of inflammatory diseases, delving into the complexities surrounding regulated cell death emerges as an indispensable and forefront area of exploration. Understanding the intricacies of how cells are regulated to undergo death in inflammatory conditions not only represents a pivotal frontier in biomedical research but also holds ...read more
Feeding a vegan World
The Eat-Lancet Planetary diet recommends at least 2/3 plant and microbial sources in the food protein portion. Such diet is recommended against obesity, cancer and to limit global warming, and might get more and more incentives in the next years. We thus need massive amounts of Plant-based food, and the ...read more
Leveraging AI for personalized pediatric neurodevelopmental support
Personalized medicine in pediatrics is a moving target dedicated to finding the right treatment, at the right time, for each individual child in each stage of development. Child development is a highly personal process, unique to each individual, something which is even more apparent in the development of children with ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Neuroimaging Correlates of 22q11.2 Deletion Syndrome: Implications for Schizophrenia Research
Current Topics in Medicinal Chemistry Recent Studies on Neural Tube Defects in Embryos of Diabetic Pregnancy: An Overview
Current Medicinal Chemistry Severe Preeclampsia
Current Women`s Health Reviews Trends in Utilization of the Pharmacological Potential of Chalcones
Current Clinical Pharmacology Algorithms and Criteria for Transcatheter Aortic Valve Replacement Patient Selection: Current Status and Future Trends
Current Pharmaceutical Design The Promise of Plant Polyphenols as the Golden Standard Skin Anti-Inflammatory Agents
Current Drug Metabolism Clinical Applications and Biosafety of Human Adult Mesenchymal Stem Cells
Current Pharmaceutical Design Metabolomics
Current Drug Metabolism A Systematic Review of Drugs in Late-Stage Development for the Treatment of Multiple Sclerosis: A Focus on Oral Synthetic Drugs
Inflammation & Allergy - Drug Targets (Discontinued) Glycosaminoglycan Sulodexide Inhibition of MMP-9 Gelatinase Secretion and Activity: Possible Pharmacological Role Against Collagen Degradation in Vascular Chronic Diseases
Current Vascular Pharmacology How Cardiomyocytes Make the Heart Old
Current Pharmaceutical Biotechnology Narrative Review of Anomalous Origin of Coronary Arteries: Pathophysiology, Management, and Treatment
Current Cardiology Reviews Role of Advanced Glycation End Products (AGEs) in Thrombogenic Abnormalities in Diabetes
Current Neurovascular Research Dietary Carbohydrates - Requirement and Recommendation in the Human Diet
Current Nutrition & Food Science Low Levels of High Density Lipoprotein Increase the Severity of Cerebral White Matter Changes:Implications for Prevention and Treatment of Cerebrovascular Diseases
Current Alzheimer Research Tissue Distribution and Pharmacodynamics of Rivastigmine after Intranasal and Intravenous Administration in Rats
Current Alzheimer Research Impact of IL-17 on Cells of the Monocyte Lineage in Health and Disease
Endocrine, Metabolic & Immune Disorders - Drug Targets Studies on Growth Kinetics of Serratia marcescens VITSD2 and Optimization of Fermentation Conditions for Serratiopeptidase Production
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry An insight into the Interaction between Clopidogrel and Proton Pump Inhibitors
Current Drug Metabolism A Review on the Role of Phytosterols: New Insights Into Cardiovascular Risk
Current Pharmaceutical Design